A genetic analysis of the validity of the Hypomanic Personality Scale

Bipolar Disorders

Volumn 17, Issue 3, 2015, Pages 331-339

  Johnson, Sheri L ^a,b   Carver, Charles S ^c   Joormann, Jutta ^c,d   Cuccaro, Michael ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c University of Miami   (United States)

^d YALE UNIVERSITY   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Dopamine; Early adversity; Genetic polymorphism; Mania risk

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASSESSMENT OF HUMANS; BIPOLAR DISORDER; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HYPOMANIC PERSONALITY SCALE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SELF REPORT; UNDERGRADUATE STUDENT; VALIDATION STUDY; CHILDHOOD TRAUMA SURVIVOR; CYCLOTHYMIA; GENETIC PREDISPOSITION; GENETICS; PERSONALITY; PERSONALITY TEST; PSYCHOLOGY; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ANKK1 PROTEIN, HUMAN; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; CATECHOL METHYLTRANSFERASE; COMT PROTEIN, HUMAN; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DRD2 PROTEIN, HUMAN; DRD4 PROTEIN, HUMAN; LIN7C PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN SERINE THREONINE KINASE; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN; TPH1 PROTEIN, HUMAN; TRYPTOPHAN HYDROXYLASE;

ADOLESCENT; ADULT; ADULT SURVIVORS OF CHILD ADVERSE EVENTS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; CYCLOTHYMIC DISORDER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; PERSONALITY; PERSONALITY INVENTORY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; RISK; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN HYDROXYLASE; YOUNG ADULT;

EID: 84928206984     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12251     Document Type: Article

References (65)

1. Depue RA, Krauss S, Spoont MR, Arbisi P. General Behavior Inventory identification of unipolar and bipolar affective conditions in a nonclinical university population. J Abnorm Psychol 1989; 98: 117-126.
2. Akiskal HS, Mendlowicz MV, Jean-Louis G et al. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. J Affect Disord 2005; 85: 45-52.
3. Eckblad M, Chapman LJ. Development and validation of a scale for hypomanic personality. J Abnorm Psychol 1986; 95: 214-222.
4. Kwapil TR, Miller MB, Zinser MC, Chapman LJ, Chapman J, Eckblad M. A longitudinal study of high scorers on the hypomanic personality scale. J Abnorm Psychol 2000; 109: 222-226.
5. Alloy LB, Abramson LY, Walshaw PD et al. Behavioral Approach System and Behavioral Inhibition System sensitivities and bipolar spectrum disorders: prospective prediction of bipolar mood episodes. Bipolar Disord 2008; 10: 310-322.
6. Jones S, Mansell W, Waller L. Appraisal of hypomania-relevant experiences: development of a questionnaire to assess positive self-dispositional appraisals in bipolar and behavioural high risk samples. J Affect Disord 2006; 93: 19-28.
7. Mansell W, Rigby Z, Tai S, Lowe C. Do current beliefs predict hypomanic symptoms beyond personality style? Factor analysis of the hypomanic attitudes and positive predictions inventory (HAPPI) and its association with hypomanic symptoms in a student population. J Clin Psychol 2008; 64: 450-465.
8. Meyer TD, Hautzinger M. Hypomanic personality, social anhedonia and impulsive nonconformity: evidence for familial aggregation? J Pers Disord 2001; 15: 281-299.
9. Nikolaus S, Antke C, Muller HW. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders. Behav Brain Res 2009; 204: 32-66.
10. Nurnberger JI Jr, Berrettini W, Simmons-Alling S, Lawrence D, Brittain H. Blunted ACTH and cortisol response to afternoon tryptophan infusion in euthymic bipolar patients. Psychiatry Res 1990; 31: 57-67.
11. Sobczak S, Honig A, Nicolson NA, Riedel WJ. Effects of acute tryptophan depletion on mood and cortisol release in first-degree relatives of type I and type II bipolar patients and healthy matched controls. Neuropsychopharmacology 2002; 27: 834-842.
12. Sobczak S, Honig A, van Duinen MA, Riedel WJ. Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies. Bipolar Disord 2002; 4: 347-356.
13. Cho HJ, Meira-Lima I, Cordeiro Q et al. Population-based and family-based studies on the serotonin transporter gene polymorphisms and BD: a systematic review and meta-analysis. Mol Psychiatry 2005; 10: 771-781.
14. Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet 2005; 133B: 110-115.
15. Chen D, Liu F, Yang C et al. Association between the TPH1 A218C polymorphism and risk of mood disorders and alcohol dependence: evidence from the current studies. J Affect Disord 2012; 138: 27-33.
16. Kishi T, Yoshimura R, Fukuo Y et al. The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2013; 263: 105-118.
17. Roche S, McKeon P. Support for tryptophan hydroxylase-2 as a susceptibility gene for bipolar affective disorder. Psychiatr Genet 2009; 19: 142-146.
18. Cousins DA, Butts K, Young AH. The role of dopamine in bipolar disorder. Bipolar Disord 2009; 11: 787-806.
19. Anand A, Verhoeff P, Seneca N et al. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry 2000; 157: 1109-1114.
20. Murphy DL, Goodwin FK, Brodie KH, Bunney WE Jr. L-dopa, dopamine, and hypomania. Am J Psychiatry 1973; 130: 79-82.
21. Berridge KC. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology 2007; 191: 391-431.
22. Strakowski SM, Sax KW, Setters MJ, Stanton SP, Keck PE. Lack of enhanced behavioral response to repeated d-amphetamine challenge in first-episode psychosis: implications for sensitization model of psychosis in humans. Biol Psychiatry 1997; 42: 749-755.
23. 99mTc] TRODAT-1. Bipolar Disord 2010; 12: 102-106.
24. Suhara T, Nakayama K, Inoue O et al. D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology 1992; 106: 14-18.
25. Perry W, Minassian A, Paulus MP et al. From mice to men: a reverse translational study of dysfunctional exploration in psychiatric disorders. Arch Gen Psychiatry 2009; 66: 1072-1080.
26. Young J, Goey A, Minassian A, Perry W, Paulus M, Geyer M. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology 2010; 208: 443-454.
27. Craddock N, Sklar P. Genetics of bipolar disorder: successful start to a long journey. Trends Genet 2009; 25: 99-105.
28. Zou YF, Wang F, Feng XL et al. Association of DRD2 gene polymorphisms with mood disorders: a meta-analysis. J Affect Disord 2012; 136: 229-237.
29. López León S, Croes EA, Sayed-Tabatabaei FA, Claes S, Broeckhoven CV, van Duijn CM. The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysis. Biol Psychiatry 2005; 57: 999-1003.
30. Lee SY, Chen SL, Chang YH et al. The ALDH2 and DRD2/ANKK1 genes interacted in bipolar II but not bipolar I disorder. Pharmacogenet Genomics 2010; 20: 500-506.
31. Elvidge G, Jones I, McCandless F, Asherson P, Owen MJ, Craddock N. Allelic variation of a BalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: results of analysis and meta-analysis. Am J Med Genet 2001; 105: 307-311.
32. Zhang Z, Lindpaintner K, Che R et al. The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis. J Neural Transm 2009; 116: 1193-1200.
33. Navakkode S, Sajikumar S, Korte M, Soong TW. Dopamine induces LTP differentially in apical and basal dendrites through BDNF and voltage-dependent calcium channels. Learn Mem 2012; 19: 294-299.
34. Shirayama Y, Chaki S. Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents. Curr Neuropharmacol 2006; 4: 277-291.
35. Dwivedi Y. Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis Treat 2009; 5: 433-449.
36. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook EH Jr. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004; 161: 1698-1700.
37. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002; 71: 651-655.
38. Sklar P, Gabriel SB, McInnis MG et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry 2002; 7: 579-593.
39. Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet B 2005; 139B: 51-53.
40. Liu L, Foroud T, Xuei X et al. Evidence of association between brain-derived neurotrophic factor gene and bipolar disorder. Psychiatr Genet 2008; 18: 267-274.
41. Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, Tsuang MT. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr Genet 2007; 17: 165-170.
42. Lanktree M, Squassina A, Krinsky M et al. Association study of brain-derived neurotrophic factor (BDNF) and LIN-7 homolog (LIN-7) genes with adult attention-deficit/hyperactivity disorder. Am J Med Genet B 2008; 147B: 945-951.
43. Reuter M, Schmitz A, Corr P, Henning J. Molecular genetic support Gray's personality theory: the interaction of COMT and DRD2 polymorphisms predicts the behavioural approach system. Int J Neuropsychopharmacol 2006; 9: 155-166.
44. Montag C, Markett S, Basten U et al. Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met polymorphism impacts novelty seeking and harm avoidance. Neuropsychopharmacology 2010; 35: 1860-1867.
45. Canli T, Lesch KP. Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci 2007; 10: 1103-1109.
46. Juhasz G, Dunham JS, McKie S et al. The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions. Biol Psychiatry 2011; 69: 762-771.
47. Wichers M, Kenis G, Jacobs N et al. The BDNF Val66Met × 5-HTTLPR × child adversity interaction and depressive symptoms: an attempt at replication. Am J Med Genet B 2008; 147B: 120-123.
48. Casey BJ, Glatt CE, Tottenham N et al. Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development. Neuroscience 2009; 164: 108-120.
49. Miller S, Hallmayer J, Wang PW, Hill SJ, Johnson SL, Ketter TA. Brain-derived neurotrophic factor Val66Met genotype and early life stress effects upon bipolar course. J Psychiatr Res 2013; 47: 252-258.
50. Daruy-Filho L, Brietzke E, Lafer B, Grassi-Oliveira R. Childhood maltreatment and clinical outcomes of bipolar disorder. Acta Psychiatr Scand 2011; 124: 427-434.
51. Lovic V, Belay H, Walker CD et al. Early postnatal experience and DRD2 genotype affect dopamine receptor expression in the rat ventral striatum. Behav Brain Res 2013; 237: 278-282.
52. Taylor SE, Lerner JS, Sage RM, Lehman BJ, Seeman TE. Early environment, emotions, responses to stress, and health. J Pers 2004; 72: 1365-1393.
53. Felitti VJ, Anda RF, Nordenberg D et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. Am J Prev Med 1998; 14: 245-258.
54. Carver CS, Johnson SL, Joormann J, Kim Y, Nam JY. Serotonin transporter polymorphism interacts with childhood adversity to predict aspects of impulsivity. Psychol Sci 2011; 22: 589-595.
55. Taylor SE, Way BM, Welch WT, Hilmert CJ, Lehman BJ, Eisenberger NI. Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol Psychiatry 2006; 60: 671-676.
56. Nikolova YS, Ferrell RE, Manuck SB, Hariri AR. Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology 2011; 36: 1940-1947.
57. Carver CS, Johnson SL, Joormann J. Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression. Psychol Bull 2008; 134: 912-943.
58. Montag C, Reuter M, Newport B, Elger C, Weber B. The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study. Neuroimage 2008; 42: 1554-1559.
59. Klein DN, Depue RA, Slater JF. Inventory identification of cyclothymia. IX. Validation in offspring of bipolar I patients. Arch Gen Psychiatry 1986; 43: 441-445.
60. Reichart CG, van der Ende J, Wals M, Hillegers MHJ, Ormel J, Nolan WA. The use of the GBI in a population of adolescent offspring of parents with a bipolar disorder. J Affect Disord 2004; 80: 263-267.
61. Savitz JB, Ramesar RS. Personality: is it a viable endophenotype for genetic studies of bipolar affective disorder? Bipolar Disord 2006; 8: 322-337.
62. Thomson PA, Wray NR, Millar JK et al. Association between the TRAX//DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol Psychiatry 2005; 10: 657-668.
63. Ferreira MAR, O'Donovan MC, Meng YA et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40: 1056-1058.
64. Singh MK, DelBello MP, Chang KD. Neuroimaging Studies of Bipolar Disorder in Youth. Oxford: Oxford University Press, 2012.
65. Alloy LB, Bender RE, Whitehouse WG et al. High Behavioral Approach System (BAS) sensitivity, reward responsiveness, and goal-striving predict first onset of bipolar spectrum disorders: a prospective behavioral high-risk design. J Abnorm Psychol 2012; 121: 339-351.